Our data both identify iron uptake into the brain, and FPN1 in particular, as a target for the treatment of ischemic stroke at the acute phase, while demonstrating that long-term limitation of brain iron import will impair stroke recovery. Here, SLC40A1 is linked to stroke disorder.